Lipids and Lipoproteins in Atherosclerosis by Chroni, Angeliki et al.
Hindawi Publishing Corporation
Journal of Lipids
Volume 2011, Article ID 160104, 2 pages
doi:10.1155/2011/160104
Editorial
Lipidsand Lipoproteins inAtherosclerosis
Angeliki Chroni,1 George Leondaritis,2 and Helen Karlsson3
1Institute of Biology, National Center for Scientiﬁc Research “Demokritos”, Agia Paraskevi, 15310 Athens, Greece
2Biomedical Research Foundation of the Academy of Athens and Department of Pharmacology, Medical School, University of Thessaly,
41110 Larissa, Greece
3Department of Occupational and Environmental Medicine, Link¨ oping University Hospital, 58185 Link¨ oping, Sweden
Correspondence should be addressed to Angeliki Chroni, achroni@bio.demokritos.gr
Received 20 December 2011; Accepted 20 December 2011
Copyright © 2011 Angeliki Chroni et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Atherosclerosis is a focal disease of the arterial wall that
leads to cardiovascular disease (CVD), the biggest cause of
morbidity and mortality in Western societies. Atheroscle-
rosis is a complex, chronic, progressive disease that aﬀects
large and medium-sized arteries. Atherosclerotic lesions
are promoted by low-density lipoproteins and form from
accumulation of fatty substances, cholesterol, cellular waste
products, calcium, and ﬁbrin in the inner lining of the ar-
terial wall. Lipoproteins are complexes of amphipathic
proteins with lipids at variable ratios, densities, and sizes.
Their role is to transport water-insoluble lipids in the blood.
Plasmalipoproteinshavetraditionallybeengroupedintoﬁve
major classes, based on their buoyant density: chylomicrons,
very low-density lipoproteins (VLDL), intermediate-density
lipoproteins (IDL), low-density lipoproteins (LDL), and
high-density lipoproteins (HDL). It is believed that athero-
genic lipoproteins, such as LDL and lipoprotein remnants,
that ﬂoat in the VLDL IDL region, promote atherosclerosis,
and antiatherogenic lipoproteins, such as HDL, protect
from atherosclerosis. Despite many advances in cardiology,
atherosclerosis remains an important medical problem sug-
gesting that some steps in pathogenic mechanisms remain
unclear.
This special issue contains a series of reviews and
original research articles that seek to provide insight into
the role of lipids and lipoproteins in health and disease with
emphasis given on their implication in atherosclerosis. The
ﬁrst review by H. Itabe et al. describes the in vivo dynamics
of oxidized LDL during atherosclerosis, and the second one
by O. Tehlivets discusses the link of homocysteine, dys-
regulated lipid metabolism, and atherosclerosis. Following
these reviews new data on the prediction and pathogenesis
of atherosclerosis are presented in four research papers. M.
Enomoto et al. investigate the issue of the best predictor of
subclinical atherosclerosis and provide suggestions that the
LDL-cholesterol/HDL-cholesterol ratio is a better predictor
of carotid intima-media thickness progression than HDL-
cholesterol or LDL-cholesterol alone. J.-B. Hansen et al.
suggest that the content of apoC-I per VLDL particle is
an important regulator of triglyceride metabolism in the
fasting and postprandial state and associated with carotid
atherosclerosis. M. Guha and O. Gursky show that human
plasma VLDL are destabilized by acidic pH. They pro-
pose that the acidic environment found in the advanced
atherosclerotic plaques could destabilize VLDL, enhancing
their fusion and coalescence into lipid droplets, such as the
droplets found in atherosclerotic plaques. J. Oestvang et al.
suggest that lysophosphatidylcholine and platelet activat-
ing factor stimulate arachidonic acid release by divergent
pathways in monocytes. Elucidation of monocyte lysoPC-
speciﬁc signaling mechanisms will aid in development of
novelstrategiesforatherosclerosisprevention,diagnosis,and
therapy. Then two papers (one review and one research
paper) deal with the association of lipid abnormalities with
common diseases and predisposition to CVD. M. Peppa
et al. discuss the observed dyslipidemia and increased risk
of coronary artery disease, cerebral ischemia, and angina
pectoris in older and possibly ischemic stroke in younger2 Journal of Lipids
patients with overt or subclinical hyperthyroidism. P. M.
Rochaetal.providedatathatreinforcethecontributionofan
abdominal obesity phenotype associated with a diabetogenic
and atherothrombotic proﬁle to liver lipotoxicity.
We hope that this collective special issue will help to
update and enrich current research on atherosclerosis and
CVD.
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